News

World Congress of Nephrology, May 30-June 4, Hong Kong, China May 08 2013

BioPorto Congress Calendar 2013 April 22 2013

EUROMEDLAB, May 19-23 Milan, Italy April 22 2013

ERA-EDTA CONGRESS, May 18-22, Istanbul, Turkey April 22 2013

World Kidney Day March 14 2013

New overview - NGAL Links and Resources March 08 2013

ISICEM 2013, March 19-22, Brussels Belgium February 27 2013

Conference on Continuous Renal Replacement Therapies, February 12-15, San Diego, CA USA February 07 2013

MEDLAB Middle East / Arab Health, January 28-31, Dubai, UAE January 11 2013

ISNCON, December 6-9 Ahmedabad, India November 29 2012

next 10

An addition to the Obesity and Type 2 Diabetes antibody portfolio

December 22 2011 by BioPorto Diagnostics

BioPorto Diagnostics is pleased to announce the launch of new monoclonal antibodies

The launch of two new Anti-Glucagon (human, pig, rat) antibodies provides a tool for measuring free glucagon levels. The two antibodies are designed to work together as a sandwich antibody pair.

BioPorto Diagnostics offers an extensive range of monoclonal antibodies within the Obesity and Type 2 Diabetes area. These antibodies are widely used by researchers and pharmaceutical companies around the world. Especially in the field of obesity and type-2 diabetes, these antibodies give researchers a unique opportunity to measure relevant peptide hormones.